Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,238 | -33,291 | -102,183 | -64,092 | -74,969 |
| Depreciation Amortization | 1,931 | 964 | 3,643 | N/A | N/A |
| Accounts receivable | -2,366 | 1,845 | -981 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,383 | 487 | 5,784 | N/A | N/A |
| Other Working Capital | 644 | -664 | 7,565 | -30,859 | -5,121 |
| Other Operating Activity | 3,989 | -1,907 | 24,365 | 24,115 | 25,671 |
| Operating Cash Flow | $-65,657 | $-32,567 | $-61,807 | $-70,837 | $-54,419 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -201,916 | -200,191 | -155,405 | -158,756 | -183,678 |
| PPE Investments | -1,245 | -514 | -1,632 | -660 | -539 |
| Purchase Sale Intangibles | -143 | N/A | -1,816 | -1,291 | N/A |
| Other Investing Activity | -143 | 0 | -1,816 | -1,291 | 0 |
| Investing Cash Flow | $-203,304 | $-200,705 | $-158,854 | $-160,707 | $-184,217 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 53,372 | 53,853 | N/A | N/A | N/A |
| Common Stock Issued | 1,229,190 | 215,276 | 227,086 | 226,174 | 225,348 |
| Common Stock Repurchased | -11,693 | N/A | -6,040 | -6,074 | -6,078 |
| Other Financing Activity | -34,891 | -3,903 | -89,347 | -88,494 | -88,162 |
| Financing Cash Flow | $1,235,978 | $265,226 | $131,698 | $131,607 | $131,108 |
| Exchange Rate Effect | 659 | 527 | -1,051 | -43 | -812 |
| Beginning Cash Position | 64,836 | 65,420 | 155,253 | 156,108 | 156,215 |
| End Cash Position | 1,032,512 | 97,901 | 65,240 | 56,128 | 47,875 |
| Net Cash Flow | $967,676 | $32,481 | $-90,013 | $-99,980 | $-108,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,657 | -32,567 | -61,807 | -70,837 | -54,419 |
| Capital Expenditure | -1,245 | -514 | -1,632 | -660 | -539 |
| Free Cash Flow | -66,902 | -33,081 | -63,439 | -71,497 | -54,958 |